Concomitant usage of Diclofenac sodium extended-launch tablets and cyclosporine could increase cyclosporine’s nephrotoxicity. A dosage adjustment could be warranted when diclofenac is administered with CYP2C9 inhibitors or inducers (see Scientific PHARMACOLOGY; Pharmacokinetics). Individuals who consider nonsteroidal anti-inflammatory medications (NSAIDs) (besides aspirin) such as dic... https://winstony924mno8.gynoblog.com/profile